Global Plasma Fractionation and Blood Product Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 116
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Plasma Fractionation and Blood Product market size was valued at USD 4953.8 million in 2023 and is forecast to a readjusted size of USD 5961.1 million by 2030 with a CAGR of 2.7% during review period.
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Plasma Fractionation and Blood Product industry chain, the market status of Immunology (Coagulation Factor, Immune Globulin), Hematology (Coagulation Factor, Immune Globulin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma Fractionation and Blood Product.
Regionally, the report analyzes the Plasma Fractionation and Blood Product markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma Fractionation and Blood Product market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Plasma Fractionation and Blood Product market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma Fractionation and Blood Product industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Coagulation Factor, Immune Globulin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma Fractionation and Blood Product market.
Regional Analysis: The report involves examining the Plasma Fractionation and Blood Product market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma Fractionation and Blood Product market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Plasma Fractionation and Blood Product:
Company Analysis: Report covers individual Plasma Fractionation and Blood Product manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma Fractionation and Blood Product This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunology, Hematology).
Technology Analysis: Report covers specific technologies relevant to Plasma Fractionation and Blood Product. It assesses the current state, advancements, and potential future developments in Plasma Fractionation and Blood Product areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma Fractionation and Blood Product market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Plasma Fractionation and Blood Product market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Market segment by Application
Immunology
Hematology
Other
Major players covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma Fractionation and Blood Product product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma Fractionation and Blood Product, with price, sales, revenue and global market share of Plasma Fractionation and Blood Product from 2019 to 2024.
Chapter 3, the Plasma Fractionation and Blood Product competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Fractionation and Blood Product breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma Fractionation and Blood Product market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Fractionation and Blood Product.
Chapter 14 and 15, to describe Plasma Fractionation and Blood Product sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Plasma Fractionation and Blood Product
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma Fractionation and Blood Product Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Coagulation Factor
1.3.3 Immune Globulin
1.3.4 Albumin
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma Fractionation and Blood Product Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immunology
1.4.3 Hematology
1.4.4 Other
1.5 Global Plasma Fractionation and Blood Product Market Size & Forecast
1.5.1 Global Plasma Fractionation and Blood Product Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Plasma Fractionation and Blood Product Sales Quantity (2019-2030)
1.5.3 Global Plasma Fractionation and Blood Product Average Price (2019-2030)
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Fractionation and Blood Product Product and Services
2.1.4 Takeda Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Fractionation and Blood Product Product and Services
2.2.4 CSL Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Fractionation and Blood Product Product and Services
2.3.4 Grifols Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Fractionation and Blood Product Product and Services
2.4.4 Octapharma Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Fractionation and Blood Product Product and Services
2.5.4 Kedrion Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Fractionation and Blood Product Product and Services
2.6.4 LFB Group Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Fractionation and Blood Product Product and Services
2.7.4 Biotest Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Fractionation and Blood Product Product and Services
2.8.4 BPL Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BPL Recent Developments/Updates
2.9 RAAS
2.9.1 RAAS Details
2.9.2 RAAS Major Business
2.9.3 RAAS Plasma Fractionation and Blood Product Product and Services
2.9.4 RAAS Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Plasma Fractionation and Blood Product Product and Services
2.10.4 CBPO Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CBPO Recent Developments/Updates
2.11 Hualan Bio
2.11.1 Hualan Bio Details
2.11.2 Hualan Bio Major Business
2.11.3 Hualan Bio Plasma Fractionation and Blood Product Product and Services
2.11.4 Hualan Bio Plasma Fractionation and Blood Product Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hualan Bio Recent Developments/Updates
3.1 Global Plasma Fractionation and Blood Product Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturer (2019-2024)
3.3 Global Plasma Fractionation and Blood Product Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Plasma Fractionation and Blood Product by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Plasma Fractionation and Blood Product Manufacturer Market Share in 2023
3.4.2 Top 6 Plasma Fractionation and Blood Product Manufacturer Market Share in 2023
3.5 Plasma Fractionation and Blood Product Market: Overall Company Footprint Analysis
3.5.1 Plasma Fractionation and Blood Product Market: Region Footprint
3.5.2 Plasma Fractionation and Blood Product Market: Company Product Type Footprint
3.5.3 Plasma Fractionation and Blood Product Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Plasma Fractionation and Blood Product Market Size by Region
4.1.1 Global Plasma Fractionation and Blood Product Sales Quantity by Region (2019-2030)
4.1.2 Global Plasma Fractionation and Blood Product Consumption Value by Region (2019-2030)
4.1.3 Global Plasma Fractionation and Blood Product Average Price by Region (2019-2030)
4.2 North America Plasma Fractionation and Blood Product Consumption Value (2019-2030)
4.3 Europe Plasma Fractionation and Blood Product Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma Fractionation and Blood Product Consumption Value (2019-2030)
4.5 South America Plasma Fractionation and Blood Product Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma Fractionation and Blood Product Consumption Value (2019-2030)
5.1 Global Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2030)
5.2 Global Plasma Fractionation and Blood Product Consumption Value by Type (2019-2030)
5.3 Global Plasma Fractionation and Blood Product Average Price by Type (2019-2030)
6.1 Global Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2030)
6.2 Global Plasma Fractionation and Blood Product Consumption Value by Application (2019-2030)
6.3 Global Plasma Fractionation and Blood Product Average Price by Application (2019-2030)
7.1 North America Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2030)
7.2 North America Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2030)
7.3 North America Plasma Fractionation and Blood Product Market Size by Country
7.3.1 North America Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2030)
7.3.2 North America Plasma Fractionation and Blood Product Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2030)
8.2 Europe Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2030)
8.3 Europe Plasma Fractionation and Blood Product Market Size by Country
8.3.1 Europe Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2030)
8.3.2 Europe Plasma Fractionation and Blood Product Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Region
9.3.1 Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Plasma Fractionation and Blood Product Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2030)
10.2 South America Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2030)
10.3 South America Plasma Fractionation and Blood Product Market Size by Country
10.3.1 South America Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2030)
10.3.2 South America Plasma Fractionation and Blood Product Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma Fractionation and Blood Product Market Size by Country
11.3.1 Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Plasma Fractionation and Blood Product Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Plasma Fractionation and Blood Product Market Drivers
12.2 Plasma Fractionation and Blood Product Market Restraints
12.3 Plasma Fractionation and Blood Product Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Plasma Fractionation and Blood Product and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma Fractionation and Blood Product
13.3 Plasma Fractionation and Blood Product Production Process
13.4 Plasma Fractionation and Blood Product Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma Fractionation and Blood Product Typical Distributors
14.3 Plasma Fractionation and Blood Product Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Plasma Fractionation and Blood Product Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma Fractionation and Blood Product Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma Fractionation and Blood Product Product and Services
Table 6. Takeda Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma Fractionation and Blood Product Product and Services
Table 11. CSL Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma Fractionation and Blood Product Product and Services
Table 16. Grifols Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma Fractionation and Blood Product Product and Services
Table 21. Octapharma Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma Fractionation and Blood Product Product and Services
Table 26. Kedrion Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma Fractionation and Blood Product Product and Services
Table 31. LFB Group Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma Fractionation and Blood Product Product and Services
Table 36. Biotest Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma Fractionation and Blood Product Product and Services
Table 41. BPL Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BPL Recent Developments/Updates
Table 43. RAAS Basic Information, Manufacturing Base and Competitors
Table 44. RAAS Major Business
Table 45. RAAS Plasma Fractionation and Blood Product Product and Services
Table 46. RAAS Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Plasma Fractionation and Blood Product Product and Services
Table 51. CBPO Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CBPO Recent Developments/Updates
Table 53. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Bio Major Business
Table 55. Hualan Bio Plasma Fractionation and Blood Product Product and Services
Table 56. Hualan Bio Plasma Fractionation and Blood Product Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hualan Bio Recent Developments/Updates
Table 58. Global Plasma Fractionation and Blood Product Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 59. Global Plasma Fractionation and Blood Product Revenue by Manufacturer (2019-2024) & (USD Million)
Table 60. Global Plasma Fractionation and Blood Product Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 61. Market Position of Manufacturers in Plasma Fractionation and Blood Product, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 62. Head Office and Plasma Fractionation and Blood Product Production Site of Key Manufacturer
Table 63. Plasma Fractionation and Blood Product Market: Company Product Type Footprint
Table 64. Plasma Fractionation and Blood Product Market: Company Product Application Footprint
Table 65. Plasma Fractionation and Blood Product New Market Entrants and Barriers to Market Entry
Table 66. Plasma Fractionation and Blood Product Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Plasma Fractionation and Blood Product Sales Quantity by Region (2019-2024) & (K Units)
Table 68. Global Plasma Fractionation and Blood Product Sales Quantity by Region (2025-2030) & (K Units)
Table 69. Global Plasma Fractionation and Blood Product Consumption Value by Region (2019-2024) & (USD Million)
Table 70. Global Plasma Fractionation and Blood Product Consumption Value by Region (2025-2030) & (USD Million)
Table 71. Global Plasma Fractionation and Blood Product Average Price by Region (2019-2024) & (US$/Unit)
Table 72. Global Plasma Fractionation and Blood Product Average Price by Region (2025-2030) & (US$/Unit)
Table 73. Global Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2024) & (K Units)
Table 74. Global Plasma Fractionation and Blood Product Sales Quantity by Type (2025-2030) & (K Units)
Table 75. Global Plasma Fractionation and Blood Product Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Global Plasma Fractionation and Blood Product Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Global Plasma Fractionation and Blood Product Average Price by Type (2019-2024) & (US$/Unit)
Table 78. Global Plasma Fractionation and Blood Product Average Price by Type (2025-2030) & (US$/Unit)
Table 79. Global Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2024) & (K Units)
Table 80. Global Plasma Fractionation and Blood Product Sales Quantity by Application (2025-2030) & (K Units)
Table 81. Global Plasma Fractionation and Blood Product Consumption Value by Application (2019-2024) & (USD Million)
Table 82. Global Plasma Fractionation and Blood Product Consumption Value by Application (2025-2030) & (USD Million)
Table 83. Global Plasma Fractionation and Blood Product Average Price by Application (2019-2024) & (US$/Unit)
Table 84. Global Plasma Fractionation and Blood Product Average Price by Application (2025-2030) & (US$/Unit)
Table 85. North America Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2024) & (K Units)
Table 86. North America Plasma Fractionation and Blood Product Sales Quantity by Type (2025-2030) & (K Units)
Table 87. North America Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2024) & (K Units)
Table 88. North America Plasma Fractionation and Blood Product Sales Quantity by Application (2025-2030) & (K Units)
Table 89. North America Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2024) & (K Units)
Table 90. North America Plasma Fractionation and Blood Product Sales Quantity by Country (2025-2030) & (K Units)
Table 91. North America Plasma Fractionation and Blood Product Consumption Value by Country (2019-2024) & (USD Million)
Table 92. North America Plasma Fractionation and Blood Product Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Europe Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2024) & (K Units)
Table 94. Europe Plasma Fractionation and Blood Product Sales Quantity by Type (2025-2030) & (K Units)
Table 95. Europe Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2024) & (K Units)
Table 96. Europe Plasma Fractionation and Blood Product Sales Quantity by Application (2025-2030) & (K Units)
Table 97. Europe Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2024) & (K Units)
Table 98. Europe Plasma Fractionation and Blood Product Sales Quantity by Country (2025-2030) & (K Units)
Table 99. Europe Plasma Fractionation and Blood Product Consumption Value by Country (2019-2024) & (USD Million)
Table 100. Europe Plasma Fractionation and Blood Product Consumption Value by Country (2025-2030) & (USD Million)
Table 101. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2024) & (K Units)
Table 102. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Type (2025-2030) & (K Units)
Table 103. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2024) & (K Units)
Table 104. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Application (2025-2030) & (K Units)
Table 105. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Region (2019-2024) & (K Units)
Table 106. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity by Region (2025-2030) & (K Units)
Table 107. Asia-Pacific Plasma Fractionation and Blood Product Consumption Value by Region (2019-2024) & (USD Million)
Table 108. Asia-Pacific Plasma Fractionation and Blood Product Consumption Value by Region (2025-2030) & (USD Million)
Table 109. South America Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2024) & (K Units)
Table 110. South America Plasma Fractionation and Blood Product Sales Quantity by Type (2025-2030) & (K Units)
Table 111. South America Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2024) & (K Units)
Table 112. South America Plasma Fractionation and Blood Product Sales Quantity by Application (2025-2030) & (K Units)
Table 113. South America Plasma Fractionation and Blood Product Sales Quantity by Country (2019-2024) & (K Units)
Table 114. South America Plasma Fractionation and Blood Product Sales Quantity by Country (2025-2030) & (K Units)
Table 115. South America Plasma Fractionation and Blood Product Consumption Value by Country (2019-2024) & (USD Million)
Table 116. South America Plasma Fractionation and Blood Product Consumption Value by Country (2025-2030) & (USD Million)
Table 117. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Type (2019-2024) & (K Units)
Table 118. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Type (2025-2030) & (K Units)
Table 119. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Application (2019-2024) & (K Units)
Table 120. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Application (2025-2030) & (K Units)
Table 121. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Region (2019-2024) & (K Units)
Table 122. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity by Region (2025-2030) & (K Units)
Table 123. Middle East & Africa Plasma Fractionation and Blood Product Consumption Value by Region (2019-2024) & (USD Million)
Table 124. Middle East & Africa Plasma Fractionation and Blood Product Consumption Value by Region (2025-2030) & (USD Million)
Table 125. Plasma Fractionation and Blood Product Raw Material
Table 126. Key Manufacturers of Plasma Fractionation and Blood Product Raw Materials
Table 127. Plasma Fractionation and Blood Product Typical Distributors
Table 128. Plasma Fractionation and Blood Product Typical Customers
List of Figures
Figure 1. Plasma Fractionation and Blood Product Picture
Figure 2. Global Plasma Fractionation and Blood Product Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma Fractionation and Blood Product Consumption Value Market Share by Type in 2023
Figure 4. Coagulation Factor Examples
Figure 5. Immune Globulin Examples
Figure 6. Albumin Examples
Figure 7. Other Examples
Figure 8. Global Plasma Fractionation and Blood Product Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Plasma Fractionation and Blood Product Consumption Value Market Share by Application in 2023
Figure 10. Immunology Examples
Figure 11. Hematology Examples
Figure 12. Other Examples
Figure 13. Global Plasma Fractionation and Blood Product Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global Plasma Fractionation and Blood Product Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global Plasma Fractionation and Blood Product Sales Quantity (2019-2030) & (K Units)
Figure 16. Global Plasma Fractionation and Blood Product Average Price (2019-2030) & (US$/Unit)
Figure 17. Global Plasma Fractionation and Blood Product Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global Plasma Fractionation and Blood Product Consumption Value Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of Plasma Fractionation and Blood Product by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 20. Top 3 Plasma Fractionation and Blood Product Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Top 6 Plasma Fractionation and Blood Product Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Global Plasma Fractionation and Blood Product Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global Plasma Fractionation and Blood Product Consumption Value Market Share by Region (2019-2030)
Figure 24. North America Plasma Fractionation and Blood Product Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe Plasma Fractionation and Blood Product Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific Plasma Fractionation and Blood Product Consumption Value (2019-2030) & (USD Million)
Figure 27. South America Plasma Fractionation and Blood Product Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa Plasma Fractionation and Blood Product Consumption Value (2019-2030) & (USD Million)
Figure 29. Global Plasma Fractionation and Blood Product Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global Plasma Fractionation and Blood Product Consumption Value Market Share by Type (2019-2030)
Figure 31. Global Plasma Fractionation and Blood Product Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global Plasma Fractionation and Blood Product Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global Plasma Fractionation and Blood Product Consumption Value Market Share by Application (2019-2030)
Figure 34. Global Plasma Fractionation and Blood Product Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America Plasma Fractionation and Blood Product Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America Plasma Fractionation and Blood Product Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America Plasma Fractionation and Blood Product Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America Plasma Fractionation and Blood Product Consumption Value Market Share by Country (2019-2030)
Figure 39. United States Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Canada Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Mexico Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Europe Plasma Fractionation and Blood Product Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe Plasma Fractionation and Blood Product Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe Plasma Fractionation and Blood Product Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe Plasma Fractionation and Blood Product Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. France Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. United Kingdom Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Russia Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Italy Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific Plasma Fractionation and Blood Product Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific Plasma Fractionation and Blood Product Consumption Value Market Share by Region (2019-2030)
Figure 55. China Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Japan Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Korea Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. India Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Southeast Asia Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Australia Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. South America Plasma Fractionation and Blood Product Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America Plasma Fractionation and Blood Product Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America Plasma Fractionation and Blood Product Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America Plasma Fractionation and Blood Product Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Argentina Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa Plasma Fractionation and Blood Product Sales Quantity Market Share by Region (2019-2030)
Figure 70. Middle East & Africa Plasma Fractionation and Blood Product Consumption Value Market Share by Region (2019-2030)
Figure 71. Turkey Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Egypt Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Saudi Arabia Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. South Africa Plasma Fractionation and Blood Product Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Plasma Fractionation and Blood Product Market Drivers
Figure 76. Plasma Fractionation and Blood Product Market Restraints
Figure 77. Plasma Fractionation and Blood Product Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Plasma Fractionation and Blood Product in 2023
Figure 80. Manufacturing Process Analysis of Plasma Fractionation and Blood Product
Figure 81. Plasma Fractionation and Blood Product Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Takeda CSL Grifols Octapharma Kedrion LFB Group Biotest BPL RAAS CBPO Hualan Bio
Related Reports
29 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
